Abstract
Cancer remains one of the leading causes of death and is driven by complex interactions among oxidative stress, inflammation, and dysregulated cellular signaling. Over the past few years, plant-derived antioxidants have shown exciting anticancer potential in preclinical trials. However, translating these findings into effective clinical therapies remains a challenge. Moreover, their safety profile depends on the individual compound, dosage, formulation, and duration of exposure. This review provides a comprehensive overview of plant-derived antioxidants and their therapeutic potential in cancer prevention and treatment, with particular emphasis on their molecular mechanisms, biological activities, and translational relevance. Plant-derived compounds exhibit significant anticancer potential through the regulation of signaling pathways such as NF-κB, PI3K/Akt, MAPK, and Nrf2, thereby influencing cell proliferation, apoptosis, angiogenesis, inflammation, and metastasis. Despite this promising therapeutic potential, their clinical application remains challenging. Recent advances in drug delivery systems have shown their considerable promise in overcoming these limitations and enhancing their therapeutic efficacy. Consequently, natural antioxidants may represent a multi-targeted and biologically relevant strategy for cancer management. However, further mechanistic studies and well-designed clinical trials are needed to validate their therapeutic potential and support their integration into modern oncology, ultimately contributing to the development of safer and more effective anticancer therapies.